In accomplishing its mission of data and project management and coordination DAAC provides expertise in the following areas:
| Completed Data Management Projects/Studies
|
||
| Non-alcoholic steatohepatitis (NASH) prevalence estimation and risk stratification using a multi-system regional research network database | Pfizer via PCORnet
12/3/2019-11/30/2021 |
Data Analysis study
7 sites |
| Learning Health Systems Network- LHSNet – National patient-centered research network clinical data research network (CDRN) Phase II | PCORnet
9/30/2015—3/30/2019
|
7 sites/~1.07 million Patients in the OSU PCORnet CDM
5 Studies/2 Clinical Trials |
| PaTH Network (PCORnet CRN) People Centered Research Foundation (PCRF) | PCORnet, 11/01/108 – current | 7 sites/1.07 million currently
2 Clinical Trials (continued from LHSNet) |
| Influenza Vaccine to Effectively Stop Cardio Thoracic Events & Decompensated heart failure | PCORnet Clinical trial,
09-08-2017 – current |
9 subjects enrolled at OSU
23 PCORnet Sites |
| Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness | PCORnet Clinical Trial, 04/01/2016-06/30/2020 | 92 subjects enrolled at OSU
41 sites |
| TVTR – Transcatheter Valve Therapy registry | PCORnet, 2016-2018 | 6 sites/ 2809 Patients linked |
| PCSK9 Inhibitors | PCORnet, 2017-2018 | 7 CDRNs/5 sites from LHSNet |
| Heart Failure (HF) Cohort | PCORnet, 2017- 2019 | 4 Sites 416 responses from OSU patients |
| Osteogenesis Imperfecta (OI) Cohort | PCORnet, 2017- 2019 | 4 Sites 20-30 responses from OSU patients |
| Weight Cohort | PCORnet, 2017 – 2019 | 5 Sites; 2799 total responses from 5 sites |
| Characterizing patients with Severe hypertriglyceridemia (sHTG) and Atherosclerotic CVD (ASCVD) using a Multi-System Regional Research Network Database | Pfizer via PCORnet
11/9/2021-6/30/2022 |
Data Analysis study
7 sites |
| Kidney CRG Nephrotic Syndrome Validation | Arbor Research via PCORnet | CP validation study; 10 sites |
| HEalth Care Worker pROphylaxis Against COVID-19 (HERO) registry / HERO trial | PCORnet/DCRI | double-blinded RCT
H34 US sites |